Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 11.69 is 94% above its 2-year average of 6.03, near the high end of its 2-year range (0.00–11.69).
As of the fiscal period ended Tuesday, June 30, 2026. 25.99% above its 12-month average of 9.28.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 11.69.
CURRENT RATIO
11.69
CURRENT RATIO AVG TTM
9.28
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+25.99%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.58
median of 752 covered companies
CURRENT VS SECTOR MEDIAN
+226.51%
vs the sector median at left
Market Cap
$4.69B
Current Ratio
1.38
TTM Avg
1.51
3Y Avg
1.37
5Y Avg
1.46
Market Cap
$4.42B
Current Ratio
0.84
TTM Avg
0.80
3Y Avg
0.95
5Y Avg
1.27
Market Cap
$4.39B
Current Ratio
4.79
TTM Avg
3.12
3Y Avg
4.00
5Y Avg
4.41
Market Cap
$4.70B
Current Ratio
6.95
TTM Avg
6.77
3Y Avg
6.23
5Y Avg
10.87
Market Cap
$4.37B
Current Ratio
5.08
TTM Avg
3.83
3Y Avg
4.06
5Y Avg
4.06
Market Cap
$4.37B
Current Ratio
16.24
TTM Avg
19.89
3Y Avg
20.20
5Y Avg
22.94
Market Cap
$4.84B
Current Ratio
38.51
TTM Avg
25.63
3Y Avg
37.00
5Y Avg
29.64
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BillionToOne, Inc. (BLLN) | $4.56B | 11.69 | 9.28 | N/A | N/A |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 1.47 | 1.61 | 1.69 | 1.64 |
| LifeStance Health Group, Inc. (LFST)vs › | $4.69B | 1.38 | 1.51 | 1.37 | 1.46 |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.42B | 0.84 | 0.80 | 0.95 | 1.27 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.39B | 4.79 | 3.12 | 4.00 | 4.41 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.70B | 6.95 | 6.77 | 6.23 | 10.87 |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.37B | 5.08 | 3.83 | 4.06 | 4.06 |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.37B | 16.24 | 19.89 | 20.20 | 22.94 |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.84B | 38.51 | 25.63 | 37.00 | 29.64 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.82B | 26.10 | 14.27 | 14.23 | 14.47 |
Current Ratio
11.69
Quick Ratio
11.31
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 11.69 |
| 2026-03-31 | 10.92 |
| 2025-12-31 | 11.69 |
| 2025-09-30 | 6.17 |
| 2025-06-30 | 5.92 |
| 2025-03-31 | 5.92 |
| 2024-12-31 | 8.03 |
| 2024-09-30 | 0.00 |
| 2024-06-30 | 0.00 |
| 2024-03-31 | 0.00 |
